EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 62017TN0419
Case T-419/17: Action brought on 4 July 2017 — Mendes v EUIPO — Actial Farmaceutica (VSL#3)
Case T-419/17: Action brought on 4 July 2017 — Mendes v EUIPO — Actial Farmaceutica (VSL
3)
Case T-419/17: Action brought on 4 July 2017 — Mendes v EUIPO — Actial Farmaceutica (VSL
3)
OJ C 277, 21.8.2017, p. 55–56
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
21.8.2017 |
EN |
Official Journal of the European Union |
C 277/55 |
Action brought on 4 July 2017 — Mendes v EUIPO — Actial Farmaceutica (VSL#3)
(Case T-419/17)
(2017/C 277/80)
Language in which the application was lodged: Italian
Parties
Applicant: Mendes SA (Lugano, Switzerland) (represented by: G. Carpineti, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Actial Farmaceutica Srl (Rome, Italy)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: European Union word mark ‘VSL#3’ — European Union trade mark No 1 437 789
Procedure before EUIPO: Revocation proceedings
Contested decision: Decision of the Second Board of Appeal of EUIPO of 3 May 2017 in Case R 1306/2016-2
Form of order sought
The applicant claims that the Court should:
— |
primarily, annul the contested decision of the Board of Appeal of EUIPO in accordance with and for the purposes of Article 51(1)(b) EUTMR; |
— |
in the alternative, annul the contested decision of the Board of Appeal of EUIPO in accordance with and for the purposes of Article 51(1)(c) EUTMR; |
— |
in any event, order that the applicant should be reimbursed in full for the costs of the proceedings, or at least that each party should bear its own costs in full. |
Plea in law
— |
Infringement of Article 51(1)(b) and (c) of Regulation No 207/2009. |